| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Repayment of loan | 0 | - |
| Net cash provided by financing activities | 1,152,684 | 1,003,218 |
| Net increase (decrease) in cash | -2,435,443 | -1,420,906 |
| Cash and cash equivalents at beginning of period | 3,229,480 | - |
| Cash and cash equivalents at end of period | 794,036 | - |
ENDRA Life Sciences Inc. (NDRA)
ENDRA Life Sciences Inc. (NDRA)